This is a retrospective chart review study looking at the assessment of the clinical performance of single gene non-invasive prenatal screening and comparison to standard of care.

The purpose of this clinical trial is to assess the safety and effectiveness of a new device called the KOKO device. This device will be used on women who have postpartum hemorrhage after they deliver their baby.